chevron_leftBack
As of 11 June 2026, Johnson Chemical Pharmaceutical Works Co., Ltd. has a market cap of $78.7M USD, ranking #27255 globally and #1550 in Taiwan.
It ranks #2446 in the Healthcare sector, and #881 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$78.7MUSD
2.49B TWD
Enterprise Value
$50.5MUSD
1.6B TWD
Revenue (TTM)
$18.03MUSD
569.77M TWD
EBITDA (TTM)
$2.96MUSD
93.67M TWD
Net Income (TTM)
$1.69MUSD
53.51M TWD
EBITDA Margin
16%
Profit Margin
9.4%
PE Ratio
46.2
PS Ratio
4.4
PB Ratio
1.5
EV/EBITDA
17.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Baixiong Huang
open_in_new
Employees
172
Founded
1959
Website
jcpjohnson.com.tw
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.4% | 5.4% | 1.3% | -5.5% | -20% | -21% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
4747
強生化學製藥廠股份有限公司
ISIN: TW0004747001
Shares Out.:
Shares Outstanding:
45.461M1
Shares Float:
33.599M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
55.00 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Johnson Chemical Pharmaceutical Works Co., Ltd.
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is based in New Taipei City, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6446
|
$7.76B
10K%
245.34B TWD
|
48.6
|
|
TWSE: 1795
|
$1.83B
2K%
57.95B TWD
|
12.2
|
|
TPEX: 4123
|
$921.32M
1K%
29.11B TWD
|
3.4
|
|
TPEX: 6535
|
$805.6M
924%
25.46B TWD
|
-
|
|
TPEX: 4743
|
$785.52M
898%
24.82B TWD
|
-
|
|
TPEX: 4105
|
$581.47M
639%
18.38B TWD
|
11.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
968K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
695K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
458K%
|
97.4
|
|
SIX: RO
|
$321.16B
408K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.62B
367K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.35B
349K%
218.9B CHF
|
20.5
|
chevron_leftBack